BRAF and melanoma: This dataset compares 4 drug-tolerant states (neural crest stem cell, invasive, “starved-like” melanoma cell, and pigmented) that are present in MRD following BRAFi + MEKi in BRAF-mutant melanoma patient–derived xenografts (PDXs).